Skip to main content
NMTC logo

NeuroOne Medical Technologies Corporation

NMTCNASDAQHealthcareMedical Devices

$0.80Today:- (-)1Y +23.25%

As of Oct 26, 2026 close

Market cap
$7.03M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$0.55$5.64
Volume (live)
-
Avg. volume (3M)
162.93K

NeuroOne Medical Technologies (NMTC) Financial Ratios

For fiscal 2025 (fiscal year ended Sep 30, 2025), NeuroOne Medical Technologies had return on equity of -91.3% (up from -348.4%), debt-to-equity of 0.04 (down from 0.32), a current ratio of 4.44 (up from 2.09) and return on assets of -32.7% (up from -110.3%). A current ratio of 4.44 means current assets exceed current liabilities.

NeuroOne Medical Technologies Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021
Period endingSep 2025Sep 2024Sep 2023Sep 2022Sep 2021
Valuation Ratios
P/S Ratio3.678.836.2512.92195.10
P/B Ratio6.2837.113.412.857.23
Price/Tangible Book6.3240.423.462.897.38
Enterprise Value Ratios
EV/Revenue3.038.455.418.23159.21
Profitability & Returns
Return on Equity (ROE)-91.34%-348.39%-149.61%-123.77%-230.81%
Return on Assets (ROA)-32.70%-110.33%-71.43%-60.39%-100.59%
Return on Capital Employed (ROCE)-49.80%-376.60%-189.60%-103.20%-151.20%
Leverage & Solvency Ratios
Debt/Equity0.040.320.030.020.05
Liquidity Ratios
Current Ratio4.442.094.083.936.17
Quick Ratio3.400.742.973.615.88
Efficiency Ratios
Asset Turnover1.500.510.330.200.04
Inventory Turnover3.683.416.9412.88-
Yield & Distribution Ratios
Earnings Yield-8.11%-40.38%-55.68%-36.50%-20.99%
FCF Yield-6.57%-36.49%-62.31%-28.46%-18.29%
Buyback Yield-50.03%-47.69%-13.27%-49.56%-97.52%

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About NeuroOne Medical Technologies Financial Ratios

What is NeuroOne Medical Technologies's return on equity?

NeuroOne Medical Technologies's return on equity (ROE) was -91.3% for fiscal 2025 (period ended Sep 30, 2025). It was -348.4% a year earlier.

What is NeuroOne Medical Technologies's debt-to-equity ratio?

NeuroOne Medical Technologies's debt-to-equity ratio was 0.04 for fiscal 2025 (period ended Sep 30, 2025). It was 0.32 a year earlier.

What is return on equity (ROE)?

Return on equity is net income divided by shareholders' equity. It measures how much profit a company generates from the capital its shareholders have invested. Full definition